IDO1 plays an immunosuppressive role in 2,4,6-Trinitrobenzene sulfate-induced colitis in mice

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 3057-3064

  Takamatsu, Manabu ^a   Hirata, Akihiro ^a   Ohtaki, Hirofumi ^a   Hoshi, Masato ^b   Hatano, Yuichiro ^a   Tomita, Hiroyuki ^a   Kuno, Toshiya ^a   Saito, Kuniaki ^c   Hara, Akira ^a  

^a GIFU UNIVERSITY   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; N METHYLTRYPTOPHAN; TRANSCRIPTION FACTOR FOXP3; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME ACTIVITY; IMMUNOMODULATION; INTERSTITIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; COLITIS; DISEASE MODELS, ANIMAL; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; TRINITROBENZENES;

EID: 84884262217     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203306     Document Type: Article

References (46)

1. Tang, Q., and J. A. Bluestone. 2008. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9: 239-244.
2. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
3. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21.
4. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
5. Siegmund, K., M. Feuerer, C. Siewert, S. Ghani, U. Haubold, A. Dankof, V. Krenn, M. P. Schön, A. Scheffold, J. B. Lowe, et al. 2005. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106: 3097-3104.
6. Suffia, I., S. K. Reckling, G. Salay, and Y. Belkaid. 2005. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J. Immunol. 174: 5444-5455.
7. Yurchenko, E., M. Tritt, V. Hay, E. M. Shevach, Y. Belkaid, and C. A. Piccirillo. 2006. CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J. Exp. Med. 203: 2451-2460.
8. Sather, B. D., P. Treuting, N. Perdue, M. Miazgowicz, J. D. Fontenot, A. Y. Rudensky, and D. J. Campbell. 2007. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204: 1335-1347.
9. Clark, R. A., B. Chong, N. Mirchandani, N. K. Brinster, K. Yamanaka, R. K. Dowgiert, and T. S. Kupper. 2006. The vast majority of CLA+ T cells are resident in normal skin. J. Immunol. 176: 4431-4439.
10. Mempel, T. R., S. E. Henrickson, and U. H. Von Andrian. 2004. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427: 154-159.
11. Cahalan, M. D., and I. Parker. 2008. Choreography of cell motility and interaction dynamics imaged by two-photon microscopy in lymphoid organs. Annu. Rev. Immunol. 26: 585-626.
12. Tang, Q., J. Y. Adams, A. J. Tooley, M. Bi, B. T. Fife, P. Serra, P. Santamaria, R. M. Locksley, M. F. Krummel, and J. A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7: 83-92.
13. Mempel, T. R., M. J. Pittet, K. Khazaie, W. Weninger, R. Weissleder, H. von Boehmer, and U. H. von Andrian. 2006. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25: 129-141.
14. Kawakami, N., U. V. Nägerl, F. Odoardi, T. Bonhoeffer, H. Wekerle, and A. Flügel. 2005. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J. Exp. Med. 201: 1805-1814.
15. Mrass, P., H. Takano, L. G. Ng, S. Daxini, M. O. Lasaro, A. Iparraguirre, L. L. Cavanagh, U. H. von Andrian, H. C. Ertl, P. G. Haydon, and W. Weninger. 2006. Random migration precedes stable target cell interactions of tumorinfiltrating T cells. J. Exp. Med. 203: 2749-2761.
16. Matheu, M. P., C. Beeton, A. Garcia, V. Chi, S. Rangaraju, O. Safrina, K. Monaghan, M. I. Uemura, D. Li, S. Pal, et al. 2008. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity 29: 602-614.
17. Gebhardt, T., P. G. Whitney, A. Zaid, L. K. Mackay, A. G. Brooks, W. R. Heath, F. R. Carbone, and S. N. Mueller. 2011. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature 477: 216-219.
18. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
19. Deane, J. A., L. D. Abeynaike, M. U. Norman, J. L. Wee, A. R. Kitching, P. Kubes, and M. J. Hickey. 2012. Endogenous regulatory T cells adhere in inflamed dermal vessels via ICAM-1: association with regulation of effector leukocyte adhesion. J. Immunol. 188: 2179-2188.
20. Fan, Z., J. A. Spencer, Y. Lu, C. M. Pitsillides, G. Singh, P. Kim, S. H. Yun, V. Toxavidis, T. B. Strom, C. P. Lin, and M. Koulmanda. 2010. In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response. Nat. Med. 16: 718-722.
21. Fujisaki, J., J. Wu, A. L. Carlson, L. Silberstein, P. Putheti, R. Larocca, W. Gao, T. I. Saito, C. Lo Celso, H. Tsuyuzaki, et al. 2011. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474: 216-219.
22. Norman, M. U., S. Hulliger, P. Colarusso, and P. Kubes. 2008. Multichannel fluorescence spinning disk microscopy reveals early endogenous CD4 T cell recruitment in contact sensitivity via complement. J. Immunol. 180: 510-521.
23. Norman, M. U., N. Van De Velde, J. R. Timoshanko, A. Issekutz, and M. J. Hickey. 2003. Overlapping roles of endothelial selectins and VCAM-1 in immune complex-induced leukocyte recruitment in the cremasteric microvasculature. Am. J. Pathol. 163: 1491-1503.
24. Dudeck, A., J. Dudeck, J. Scholten, A. Petzold, S. Surianarayanan, A. Köhler, K. Peschke, D. Vöhringer, C. Waskow, T. Krieg, et al. 2011. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34: 973-984.
25. Yokoyama, K., N. Ishikawa, S. Igarashi, N. Kawano, N. Masuda, W. Hamaguchi, S. Yamasaki, Y. Koganemaru, K. Hattori, T. Miyazaki, et al. 2009. Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines. Bioorg. Med. Chem. 17: 64-73.
26. Ramos, L., G. Peña, B. Cai, E. A. Deitch, and L. Ulloa. 2010. Mast cell stabilization improves survival by preventing apoptosis in sepsis. J. Immunol. 185: 709-716.
27. Hwang, J. M., J. Yamanouchi, P. Santamaria, and P. Kubes. 2004. A critical temporal window for selectin-dependent CD4+ lymphocyte homing and initiation of late-phase inflammation in contact sensitivity. J. Exp. Med. 199: 1223-1234.
28. Kaplan, D. H., B. Z. Igyártó, and A. A. Gaspari. 2012. Early immune events in the induction of allergic contact dermatitis. Nat. Rev. Immunol. 12: 114-124.
29. Lehtimaki, S., T. Savinko, K. Lahl, T. Sparwasser, H. Wolff, A. Lauerma, H. Alenius, and N. Fyhrquist. 2012. The temporal and spatial dynamics of Foxp3+ Treg cell-mediated suppression during contact hypersensitivity responses in a murine model. J. Invest. Dermatol. 132: 2744-2751.
30. Tomura, M., T. Honda, H. Tanizaki, A. Otsuka, G. Egawa, Y. Tokura, H. Waldmann, S. Hori, J. G. Cyster, T. Watanabe, et al. 2010. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J. Clin. Invest. 120: 883-893.
31. Gebhardt, T., L. M. Wakim, L. Eidsmo, P. C. Reading, W. R. Heath, and F. R. Carbone. 2009. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat. Immunol. 10: 524-530.
32. Jiang, X., R. A. Clark, L. Liu, A. J. Wagers, R. C. Fuhlbrigge, and T. S. Kupper. 2012. Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature 483: 227-231.
33. Clark, R. A., R. Watanabe, J. E. Teague, C. Schlapbach, M. C. Tawa, N. Adams, A. A. Dorosario, K. S. Chaney, C. S. Cutler, N. R. Leboeuf, et al. 2012. Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci. Transl. Med. 4: 117ra7.
34. da Silva, H. B., S. S. Caetano, I. Monteiro, I. Gómez-Conde, K. Hanson, C. Penha-Gonçalves, D. N. Olivieri, M. M. Mota, C. R. Marinho, M. R. D'Imperio Lima, and C. E. Tadokoro. 2012. Early skin immunological disturbance after Plasmodium-infected mosquito bites. Cell. Immunol. 277: 22-32.
35. Rivas, M. N., Y. T. Koh, A. Chen, A. Nguyen, Y. H. Lee, G. Lawson, and T. A. Chatila. 2012. MyD88 is critically involved in immune tolerance breakdown at environmental interfaces of Foxp3-deficient mice. J. Clin. Invest. 122: 1933-1947.
36. Wang, X., M. Fujita, R. Prado, A. Tousson, H. C. Hsu, A. Schottelius, D. R. Kelly, P. A. Yang, Q. Wu, J. Chen, et al. 2010. Visualizing CD4 T-cell migration into inflamed skin and its inhibition by CCR4/CCR10 blockades using in vivo imaging model. Br. J. Dermatol. 162: 487-496.
37. Lehtimäki, S., S. Tillander, A. Puustinen, S. Matikainen, T. Nyman, N. Fyhrquist, T. Savinko, M. L. Majuri, H. Wolff, H. Alenius, and A. Lauerma. 2010. Absence of CCR4 exacerbates skin inflammation in an oxazolone-induced contact hypersensitivity model. J. Invest. Dermatol. 130: 2743-2751.
38. Boehm, F., M. Martin, R. Kesselring, G. Schiechl, E. K. Geissler, H. J. Schlitt, and S. Fichtner-Feigl. 2012. Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation. BMC Gastroenterol. 12: 97.
39. Yu, J., J. Sun, S. E. Wang, H. Li, S. Cao, Y. Cong, J. Liu, and X. Ren. 2011. Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis. Clin. Dev. Immunol. 2011: 469135.
40. Batista, C. E., C. Juhász, O. Muzik, W. J. Kupsky, G. Barger, H. T. Chugani, S. Mittal, S. Sood, P. K. Chakraborty, and D. C. Chugani. 2009. Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors. Mol. Imaging Biol. 11: 460-466.
41. Schroecksnadel, K., C. Winkler, L. C. Fuith, and D. Fuchs. 2005. Tryptophan degradation in patients with gynecological cancer correlates with immune activation. Cancer Lett. 223: 323-329.
42. Yoshida, N., K. Ino, Y. Ishida, H. Kajiyama, E. Yamamoto, K. Shibata, M. Terauchi, A. Nawa, H. Akimoto, O. Takikawa, et al. 2008. Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model. Clin. Cancer Res. 14: 7251-7259.
43. Katz, J. B., A. J. Muller, and G. C. Prendergast. 2008. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol. Rev. 222: 206-221.
44. Pallotta, M. T., C. Orabona, C. Volpi, C. Vacca, M. L. Belladonna, R. Bianchi, G. Servillo, C. Brunacci, M. Calvitti, S. Bicciato, et al. 2011. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat. Immunol. 12: 870-878.
45. Kushwah, R., and J. Hu. 2011. Role of dendritic cells in the induction of regulatory T cells. Cell Biosci 1: 20.
46. Fallarino, F., U. Grohmann, and P. Puccetti. 2012. Indoleamine 2,3-dioxygenase: from catalyst to signaling function. Eur. J. Immunol. 42: 1932-1937.